Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
FMC | FMC | Oct 31, 2024 | 64.99 | -2.45 |
FNF Group Of Fidelity National Financial | FNF | Oct 31, 2024 | 60.17 | -1.30 |
Focus Impact Acquisition A | FIAC | Oct 31, 2024 | 9.95 | +10.43 |
Focus Impact Acquisition Unit | FIACU | Oct 31, 2024 | 10.34 | 0.00 |
Focus Universal | FCUV | Oct 31, 2024 | 0.26 | -2.28 |
Foghorn Therapeutics | FHTX | Oct 31, 2024 | 7.62 | -5.22 |
Fomento Economico Mexicano S.A.B. de C.V. | FMX | Oct 31, 2024 | 96.89 | +0.85 |
Fonar | FONR | Oct 31, 2024 | 15.20 | -1.87 |
Foot Locker | FL | Oct 31, 2024 | 23.19 | +1.09 |
Forafric Global | AFRI | Oct 31, 2024 | 10.28 | -0.96 |
Ford Motor | F | Oct 31, 2024 | 10.29 | -1.72 |
Foremost Clean Energy | FMST | Oct 31, 2024 | 2.32 | +0.87 |
Foresight Autonomous ADR | FRSX | Oct 31, 2024 | 0.61 | -6.55 |
Forestar Group | FOR | Oct 31, 2024 | 31.57 | -1.68 |
Forge Global | FRGE | Oct 31, 2024 | 1.16 | -3.33 |
Forian | FORA | Oct 31, 2024 | 2.06 | +0.98 |
FormFactor | FORM | Oct 31, 2024 | 37.98 | -13.31 |
Formula Systems (1985) ADR | FORTY | Oct 31, 2024 | 85.20 | -2.06 |
Forrester Research | FORR | Oct 31, 2024 | 14.67 | -2.59 |
Forte Biosciences | FBRX | Oct 31, 2024 | 4.45 | -4.09 |
Fortinet | FTNT | Oct 31, 2024 | 78.66 | -0.10 |
Fortis | FTS | Oct 31, 2024 | 43.23 | 0.00 |
Fortive | FTV | Oct 31, 2024 | 71.43 | -0.92 |
Fortrea | FTRE | Oct 31, 2024 | 16.82 | -1.92 |
Fortress Biotech | FBIO | Oct 31, 2024 | 1.90 | -2.06 |
Fortress Biotech Pref | FBIOP | Oct 31, 2024 | 5.55 | -6.72 |
Fortuna Silver Mines | FSM | Oct 31, 2024 | 4.97 | -2.74 |
Fortune Brands Home & Security | FBIN | Oct 31, 2024 | 83.33 | -0.83 |
Fortune Rise Acquisition A | FRLA | Oct 31, 2024 | 11.35 | 0.00 |
Fortune Rise Acquisition Units | FRLAU | Oct 31, 2024 | 11.69 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.